These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18982517)

  • 1. Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth.
    Fei J; Lan F; Guo M; Li Y; Liu Y
    J Drug Target; 2008 Nov; 16(9):688-93. PubMed ID: 18982517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative relationship between chemical properties and bioactivities of anti-microRNA oligonucleotides targeted to tumor-associated microRNA-21.
    Nagahama K; Iseda K; Kawano D; Kawakami J
    Biochimie; 2017 Jun; 137():124-131. PubMed ID: 28302473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.
    Lu Y; Xiao J; Lin H; Bai Y; Luo X; Wang Z; Yang B
    Nucleic Acids Res; 2009 Feb; 37(3):e24. PubMed ID: 19136465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.
    Shi SJ; Zhong ZR; Liu J; Zhang ZR; Sun X; Gong T
    Pharm Res; 2012 Jan; 29(1):97-109. PubMed ID: 21732152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-miRNA oligonucleotides: A comprehensive guide for design.
    Lima JF; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    RNA Biol; 2018 Mar; 15(3):338-352. PubMed ID: 29570036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating A549 cells growth by ASO inhibiting miRNA expression.
    Wang PY; Li YJ; Zhang S; Li ZL; Yue Z; Xie N; Xie SY
    Mol Cell Biochem; 2010 Jun; 339(1-2):163-71. PubMed ID: 20049626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
    Cheng AM; Byrom MW; Shelton J; Ford LP
    Nucleic Acids Res; 2005; 33(4):1290-7. PubMed ID: 15741182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of multiple-target anti-microRNA antisense oligodeoxyribonucleotides on proliferation and migration of gastric cancer cells.
    Xu L; Dai WQ; Xu XF; Wang F; He L; Guo CY
    Asian Pac J Cancer Prev; 2012; 13(7):3203-7. PubMed ID: 22994734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification and design of anti-miRNA oligonucleotides.
    Lennox KA; Behlke MA
    Gene Ther; 2011 Dec; 18(12):1111-20. PubMed ID: 21753793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation.
    Okumura S; Hirano Y; Komatsu Y
    Sci Rep; 2021 Jun; 11(1):11467. PubMed ID: 34075147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis.
    Li Y; Zhu X; Gu J; Hu H; Dong D; Yao J; Lin C; Fei J
    Hematology; 2010 Aug; 15(4):215-21. PubMed ID: 20670480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleotide Modification of Anti-miRNA Oligonucleotides.
    Lennox KA; Vakulskas CA; Behlke MA
    Methods Mol Biol; 2017; 1517():51-69. PubMed ID: 27924473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
    Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
    J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of breast cancer cell proliferation with anti-microRNA oligonucleotides flanked by interstrand cross-linked duplexes.
    Okumura S; Hirano Y; Komatsu Y
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):225-235. PubMed ID: 31583946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
    Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the sensitivity of leukemic cells to arsenic trioxide enhanced by targeted suppression of mIRNA-21].
    Li YM; Gu JY; Zhu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):170-3. PubMed ID: 20462046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.